Gaviscon and Hyperlipidaemia - a phase IV clinical study of FDA data

Summary:

Hyperlipidaemia is reported as a side effect among people who take Gaviscon (aluminum hydroxide; magnesium trisilicate), especially for people who are female, 60+ old, also take Prilosec, and have Breast cancer.

The phase IV clinical study analyzes which people have Hyperlipidaemia when taking Gaviscon. It is created by eHealthMe based on reports of 11,990 people who have side effects when taking Gaviscon from the FDA, and is updated regularly.

What is Gaviscon?

Gaviscon has active ingredients of aluminum hydroxide; magnesium trisilicate. It is often used in gastroesophageal reflux disease. eHealthMe is studying from 12,355 Gaviscon users. Check the latest studies of Gaviscon.

What is Hyperlipidaemia?

Hyperlipidaemia (presence of excess lipids in the blood) is found to be associated with 1,428 drugs and 1,407 conditions by eHealthMe. Check the latest studies of Hyperlipidaemia.

On Jul, 06, 2026

11,990 people reported to have side effects when taking Gaviscon.
Among them, 16 people (0.13%) have Hyperlipidaemia.

Among these 16 people:

What is the gender of people who have Hyperlipidaemia when taking Gaviscon? *

female: 87.5 %
male: 12.5 %

What is the age of people who have Hyperlipidaemia when taking Gaviscon? *

What are other drugs people take besides Gaviscon? *

What are other side effects people have besides Hyperlipidaemia? *

High Blood Pressure: 16 people, 100.00%
Urinary Tract Infection: 15 people, 93.75%
Stress And Anxiety: 15 people, 93.75%
Intervertebral Disc Protrusion (spinal disc protrusion): 12 people, 75.00%
Tooth Abscess (pus formation in tooth): 12 people, 75.00%
Dermatitis Atopic (inflammatory, chronically relapsing, non-contagious and pruritic skin disorder): 11 people, 68.75%
Eczema (patches of skin become rough and inflamed, with itching and bleeding blisters): 11 people, 68.75%
Cerebral Ischaemia (insufficient blood flow to the brain to meet metabolic demand): 11 people, 68.75%
Leukocytosis (increased white blood cells): 11 people, 68.75%
Lumbar Spinal Stenosis (a medical condition in which the spinal canal narrows and compresses the spinal cord and nerves at the level of the lumbar bone): 11 people, 68.75%

What are the existing conditions these people have? *

Hot Flush (sudden feelings of heat): 11 people, 68.75%
Breast Cancer: 11 people, 68.75%
Renal Disorder (kidney disease): 3 people, 18.75%
Stress And Anxiety: 2 people, 12.50%
Blood Pressure Abnormal: 2 people, 12.50%
Depression: 2 people, 12.50%
Diarrhea: 2 people, 12.50%
Dyspnea (difficult or laboured breathing): 2 people, 12.50%
Bipolar Disorder (mood disorder): 2 people, 12.50%
Hypersensitivity: 2 people, 12.50%

* Approximation only. Some reports may have incomplete information.

Do you take Gaviscon and have Hyperlipidaemia?

- Check whether Hyperlipidaemia is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Gaviscon:

Gaviscon (12,355 reports)

Hyperlipidaemia treatments and more:

Hyperlipidaemia (86,394 reports)

How severe was Hyperlipidaemia and when was it recovered:

Hyperlipidaemia in Gaviscon

Expand to all the drugs that have ingredients of aluminum hydroxide; magnesium trisilicate:

Hyperlipidaemia and drugs with ingredients of aluminum hydroxide; magnesium trisilicate

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Gaviscon:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Hyperlipidaemia:

Hyperlipidaemia (1,428 drugs)

Browse all the conditions that are associated with Hyperlipidaemia:

Hyperlipidaemia (1,407 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on aluminum hydroxide; magnesium trisilicate (the active ingredients of Gaviscon) and Gaviscon (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.